NuVasive has been granted a patent for a spinal distraction system comprising an adjustable implant with inner and outer rods, a magnet, and a locking swivel joint. The system is designed for non-invasive treatment of spinal deformities by allowing telescopic movement and mechanical locking for precise positioning. GlobalData’s report on NuVasive gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Premium Insights NuVasive Inc - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on NuVasive, Surgical robots was a key innovation area identified from patents. NuVasive's grant share as of February 2024 was 67%. Grant share is based on the ratio of number of grants to total number of patents.

Adjustable spinal distraction system for treating spinal deformities

Source: United States Patent and Trademark Office (USPTO). Credit: NuVasive Inc

A recently granted patent (Publication Number: US11925389B2) discloses an adjustable implant designed for treating spinal deformities. The implant comprises an adjustable spinal distraction rod with an inner rod coupled to one bone portion and an outer rod coupled to another bone portion. The outer rod contains a lead screw and a magnet to facilitate telescopic movement relative to the inner rod. A locking swivel joint is included to pivot the adjustable spinal distraction rod relative to an anchor rod, securing its position mechanically. The implant's design allows for precise adjustment to address spinal deformities effectively.

Furthermore, the patent includes various claims detailing the specific features of the adjustable implant. These claims cover aspects such as the splined tip restricting rotation between the inner and outer rods, the presence of longitudinally extending channels and splines for alignment, and the inclusion of a locking swivel joint for stability. The implant's versatility is highlighted through different configurations, including options for coupling to different bone portions and intermediate structures. Overall, the patent showcases a comprehensive and innovative approach to spinal treatment through an adjustable implant with advanced features for optimal patient care.

To know more about GlobalData’s detailed insights on NuVasive, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.